Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 804.00M | $ 1.21B | $ 1.63B | $ 1.57B | $ 1.07B |
Total Assets | $ 9.48B | $ 10.68B | $ 10.17B | $ 9.98B | $ 9.88B |
Total Debt | $ 2.30B | $ 2.21B | $ 2.19B | $ 2.05B | $ 2.10B |
Net Debt | $ 1.49B | $ 1.01B | $ 561.00M | $ 478.00M | $ 1.03B |
Total Liabilities | $ 4.91B | $ 5.34B | $ 5.17B | $ 5.18B | $ 5.05B |
Stockholders Equity | $ 4.57B | $ 5.33B | $ 4.99B | $ 4.80B | $ 4.83B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |